Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.

CompletedOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

June 5, 2020

Study Completion Date

June 5, 2020

Conditions
Non Small Cell Lung Cancer
Trial Locations (15)

74374

Centre Hospitalier Annecy Genevois, Metz-Tessy

Unknown

Hôpital Ambroise Paré AP-HP, Boulogne-Billancourt

Centre Hospitalier Universitaire Brest, Brest

Centre Hospitalier Métropole Savoie, Chambéry

Centre Hospitalier Intercommunal de Créteil, Créteil

Centre Hospitalier Universitaire Grenoble Alpes, Grenoble

Centre Hospitalier de Versailles André Mignot, Le Chesnay

Centre Hospitalier Universitaire de Lille, Lille

Centre Léon Bérard Lyon, Lyon

Hospices Civils de Lyon, Lyon

Centre Hospitalier François Quesnay, Mantes-la-Jolie

Institut Curie, Paris

Institut Curie Saint Cloud, Saint-Cloud

Institut de Cancérologie Lucien Neuwirth, Saint-Etienne

Hôpital Foch, Suresnes

All Listed Sponsors
collaborator

University Hospital, Grenoble

OTHER

lead

Centre Hospitalier Annecy Genevois

OTHER

NCT04640935 - Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC. | Biotech Hunter | Biotech Hunter